Background: In Iran, both forms of cutaneous (CL) and visceral leishmaniasis (VL) have been re-ported; so the accurate species identification of the parasite(s) and the analysis of genetic diversity are necessary. Methods: The investigation was conducted from 2014 to 2015 in the northwest and south of Iran, where VL is endemic (7 provinces). Blood samples of patients and infected dogs were collected and sera separated for serologic examinations (DAT, rK39). Spleen or bone marrow samples from infected dogs were also collected to confirm the infection. DNAs of 70 samples amplified by targeting a partial sequence of ITS (18S rRNA-ITS1-5.8S rRNA-ITS2) gene. All the amplicons were sequenced and analyzed with restriction fragment length polymorph...
Two known types of cutaneous leishmaniasis (CL) including zoonotic CL due to Leishmania major and an...
Background & Aim: Visceral Leishmaniasis (VL) is an endemic disease in some parts of Iran. Leishmani...
Background and Objective: Cutaneous leishmaniasis (CL) is one of the most important diseases worldwi...
Background: In Iran, both forms of cutaneous (CL) and visceral leishmaniasis (VL) have been re-porte...
Background: Leishmaniasis is a major medical health problem and distributes in nearly half of 31 pro...
Amplification of internal transcript spacer 1 of ribosomal RNA (ITS1-RNA) gene followed by RFLP anal...
Background: In Iran, both forms of cutaneous (CL) and visceral leishmaniasis (VL) have been reported...
Copyright © 2013 Homa Hajjaran et al.This is an open access article distributed under the Creative C...
Background: Cutaneous and visceral leishmaniases are present in Fars Province in the south of Iran. ...
Leishmania infantum is the causative agent of infantile visceral leishmaniasis (IVL) in the Mediterr...
<p style="text-align: justify;">Visceral Leishmaniasis (Kala-azar) is a serious health problem in so...
Visceral leishmaniasis (VL) is endemic in Iran and is caused predominantly by Leishmania infantum, b...
Zoonotic cutaneous leishmaniasis (ZCL) is a polymorphic disease which may show various symptoms. Gen...
WOS: 000270734300012PubMed ID: 19737374Human leishmaniasis, both visceral and cutaneous, and canine ...
AbstractObjectiveTo identify Leishmania using PCR.MethodsThis study was conducted from April 2009 to...
Two known types of cutaneous leishmaniasis (CL) including zoonotic CL due to Leishmania major and an...
Background & Aim: Visceral Leishmaniasis (VL) is an endemic disease in some parts of Iran. Leishmani...
Background and Objective: Cutaneous leishmaniasis (CL) is one of the most important diseases worldwi...
Background: In Iran, both forms of cutaneous (CL) and visceral leishmaniasis (VL) have been re-porte...
Background: Leishmaniasis is a major medical health problem and distributes in nearly half of 31 pro...
Amplification of internal transcript spacer 1 of ribosomal RNA (ITS1-RNA) gene followed by RFLP anal...
Background: In Iran, both forms of cutaneous (CL) and visceral leishmaniasis (VL) have been reported...
Copyright © 2013 Homa Hajjaran et al.This is an open access article distributed under the Creative C...
Background: Cutaneous and visceral leishmaniases are present in Fars Province in the south of Iran. ...
Leishmania infantum is the causative agent of infantile visceral leishmaniasis (IVL) in the Mediterr...
<p style="text-align: justify;">Visceral Leishmaniasis (Kala-azar) is a serious health problem in so...
Visceral leishmaniasis (VL) is endemic in Iran and is caused predominantly by Leishmania infantum, b...
Zoonotic cutaneous leishmaniasis (ZCL) is a polymorphic disease which may show various symptoms. Gen...
WOS: 000270734300012PubMed ID: 19737374Human leishmaniasis, both visceral and cutaneous, and canine ...
AbstractObjectiveTo identify Leishmania using PCR.MethodsThis study was conducted from April 2009 to...
Two known types of cutaneous leishmaniasis (CL) including zoonotic CL due to Leishmania major and an...
Background & Aim: Visceral Leishmaniasis (VL) is an endemic disease in some parts of Iran. Leishmani...
Background and Objective: Cutaneous leishmaniasis (CL) is one of the most important diseases worldwi...